United States · FDA National Drug Code directory
Levetiracetam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65219-046_cf503053-d8bd-4546-b3f7-497c968dae67
- Product NDC
- 65219-046
- Form
- INJECTION
- Composition / generic term
- levetiracetam
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251212
- Source listing expiry
- 20271231
Source-listed ingredients
- LEVETIRACETAM — 15 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BAG in 1 CARTON (65219-046-71) / 100 mL in 1 BAG (65219-046-21) · 65219-046-71
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →